GSK is walking away from a core piece of its $345 million bet on Vir Biotechnology. The partners have ended their ...
Galapagos has never been afraid of reworking its pipeline or workforce to face the future. | Galapagos used its earnings ...
Once again, Insulet has broken its own records for annual revenue intake. | As CEO Jim Hollingshead noted during the investor ...
The FDA issued a safety communication this week warning Americans that if they see a smartwatch or smart ring claiming to ...
AbbVie is wrapping its tentacles around a few more oncology and immunology candidates thanks to a new $64 million deal with ...
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send ...
Frontier Medicines has just closed a $80 million fundraising, but, according to CEO Chris Varma, Ph.D., corralling the ...
Bryant had led the company for almost exactly 15 years, starting at Quidel in 2009 and overseeing operations through its $6 ...
ORI Capital has raised $260 million, the venture capital firm’s second life sciences fund that will go toward early-stage ...
After nearly a decade in the role, Agilent Technologies CEO Mike McMullen is stepping down. McMullen, who’s also currently ...
After 2023 COVID sales landed at the low end of Moderna’s estimates, company executives and investors alike are turning their ...
A drug with a past life as a potential anti-cancer agent might someday have a new job as "the pill" for men, new data in mice ...